Home / News / India News / Article / Maharashtra FDA cancels Cipla facility's drug sale licences in Pune over violations, seizes Rs 11.11 lakh stock

Maharashtra FDA cancels Cipla facility's drug sale licences in Pune over violations, seizes Rs 11.11 lakh stock

The action follows inspections conducted by the state drug regulator, which found several irregularities involving the handling, storage, records and recall of medicines

  • WhatsAppBookmarkBookmark
Listen to this article :
The FDA said the company did not fully comply with the required directions and procedures relating to the recall. Representational Pic/File

The FDA said the company did not fully comply with the required directions and procedures relating to the recall. Representational Pic/File

The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licences of Cipla Pharma & Life Sciences Ltd.'s facility at Wadki in Pune district, citing serious violations in the storage and distribution of medicines, officials said on Friday.

The action follows inspections conducted by the state drug regulator, which found several irregularities involving the handling, storage, records and recall of medicines.

Read Next Story
Reliance Group rejects Subhash Chandra’s allegations against its media entities as ‘baseless’›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All